NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: PTL Group
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Contract Signed to Start Construction of LycoRed Factory in Wujin Economic Zone - Global leader in nutrition and fortification solutions, LycoRed Limited, signed a contract for a construction project of the factory in Wujin Economic Zone (WEZ), Jiangsu province
Contract Signed to Start Construction of LycoRed Factory in Wujin Economic Zone

 

NewswireToday - /newswire/ - Shanghai, China, 2010/06/12 - Global leader in nutrition and fortification solutions, LycoRed Limited, signed a contract for a construction project of the factory in Wujin Economic Zone (WEZ), Jiangsu province.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The factory construction project is managed by PTL Group.

The contract signing ceremony was held in the Wujin administrative center in presence of Consul General of Israel in Shanghai, Jackie Eldan, Party Secretary of Wujin District, Shen Ruiqin, and Vice Mayor of Wujin, Ling Guangyao. LycoRed Limited is the first Israeli company investing in Changzhou.

“This is the first time for the Israeli company to settle in Wujin and we want to use this step as a bridge to strengthen ties and cooperation between Israel and Wujin,” said Jackie Eldan, Consul General of Israel in Shanghai.

“In the process of recommending Changzhou WEZ to LycoRed Limited, PTL Group confirmed the quality and operational advantages of the Wujin. We are already considering future projects in this fast developing region,” said Zvi Shalgo, CEO of PTL Group.

“This construction project underpins our goal of making LycoRed's unique proposition available and accessible to all of our customers, wherever in the world they operate", said Morris Zelkha, CEO of LycoRed Limited.

The construction of 7,000 square meters plant in WEZ begins immediately and it will be commissioned at the beginning of 2011.

About LycoRed

LycoRed is a world-leading supplier of value-adding nutrients and nutrient formulations to the food and beverage industry. Building on its established reputation in ingredient sourcing, quality manufacture of bespoke nutrient blends, and customer service second-to-none, LycoRed's new facility in Changzhou will be an important platform for the company's development worldwide.

About PTL Group

PTL Group (ptl-group.com) is a group of foreign and Chinese companies providing outsourced management solutions, corporate recovery and industrial project management for the foreign companies in China. Over the last 10 years PTL Group managed Chinese operations of more than 30 industrial companies from Europe and Israel.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PTL Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Contract Signed to Start Construction of LycoRed Factory in Wujin Economic Zone

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Arie Schreier - PTL-Group.com 
+86 021-64453190 sales[.]ptl-group.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PTL Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PTL Group / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer
Antibiotic Alternatives Stimulate New Product Development in Global Animal Feed Ingredient Market Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  The Franchise Group





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)